Morgan Stanley Direct Lending Fund (MSDL) offers a strong dividend, growth potential, and solid portfolio, making it a ...

Yes, there was an issue, an adjacency issue also and I will come to that second, but the general trend is that you will end ...

An uptick in initial public offering (IPO) filings in recent weeks suggests that the market for first-time biotech stocks is finally recovering after three years of sparse activity capped by share ...

Nasdaq is poised for an IPO market rebound, adding $200 million to revenue. See more on NDAQ stock and why it’s a strong buy ...

Hi, it’s Crystal Tse in New York. Welcome to today’s edition of Merger Monday, with a few consumer-related deals getting to ...

Everyone is now focused on mainstream Chinese stocks and their rallies resulting from the recent 50 basis point interest rate cut that the government just implemented there. However, these trades in ...

Most of the important news in the financial markets goes over investors' heads, only to wake up to new market price action ...

RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its ...

A second risk, and likely the biggest, is Cerebras' customer concentration. Right now, AI company G42 from the United Arab ...

Everyone knows Microsoft (NASDAQ: MSFT) and its best-known products, including the Windows operating system and Microsoft 365 ...

In its 2023-2024 exploration efforts, SAGA has identified promising geology at both its Double Mer Uranium Project and its ...

More consumer-facing companies in India are listing on India’s stock exchanges, or have big plans to IPO in months to come.